Bartosz J Grzywacz (Bartosz Grzywacz)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Top Venues

Cytometry. Part B, Clinical cytometry

Science translational medicine

Cancer immunology research

American journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Felices, Erin Wesley, Laura E Bendzick, Behiye Kodal, Rachel Hopps, Bartosz J Grzywacz, Peter Hinderlie, Jeffrey S Miller, Melissa A Geller
Reverse translation identifies the synergistic role of immune checkpoint blockade and IL-15 to enhance immunotherapy of ovarian cancer. Cancer immunology research (2023)
Frank Cichocki, Bin Zhang, Cheng-Ying Wu, Emily Chiu, Abderrahman Day, Roderick O'Connor, Dima Yackoubov, Ronit Simantov, David H McKenna, Qing Cao, Todd E DeFor, Murali Janakiram, Rose Wangen, Zuzan Cayci, Nathaniel W Snyder, Akhilesh Kumar, Bartosz J Grzywacz, Justin H Hwang, Yona Geffen, Jeffrey S Miller, Joseph E Maakaron, Veronika Bachanova
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma. Science translational medicine 15 (705) (2023)
Bartosz J Grzywacz, Sophia Yohe, Paula Shivers, Michael A Linden, Elizabeth L Courville
Patients without cutaneous T-cell lymphoma frequently harbor CD4 T-lymphocytes that lack CD26 and/or CD7. Cytometry. Part B, Clinical cytometry (2021)
Andrew B Stone, Bartosz J Grzywacz, Elizabeth L Courville, Michael A Linden
Indolent B-Lineage Precursor Populations Identified by Flow Cytometry and Immunohistochemistry in Benign Lymph Nodes. American journal of clinical pathology (2021)